Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

MaxCyte and Adicet partner to develop off-the-shelf T-cell therapies

Summary by BioProcess International
The collaboration will focus on expanding nonviral gene therapies for production and commercialization.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

BioProcess InternationalBioProcess International

MaxCyte and Adicet partner to develop off-the-shelf T-cell therapies

The collaboration will focus on expanding nonviral gene therapies for production and commercialization.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

BioProcess International broke the news in on Wednesday, August 13, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Australia icon

Australia

News
For You
SearchBlindspotLocal